Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge

Journal of Virology

Volumn 72, Issue 6, 1998, Pages 4704-4711

  Roberts, Anjeanette ^a   Kretzschmar, Evelyne ^a,c   Perkins, Archibald S ^a   Forman, John ^a   Price, Ryan ^a   Buonocore, Linda ^a   Kawaoka, Yoshihiro ^b,d   Rose, John K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c Gesell f Transfusionmedizin D   (Germany)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; INFECTION PREVENTION; INFLUENZA VIRUS A; LD 50; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINATION; VESICULAR STOMATITIS VIRUS; VIRUS INHIBITION;

EID: 0031926260     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.6.4704-4711.1998     Document Type: Article

References (26)

1. Barna, M., T. Komatsu, Z. Bi, and C. S. Reiss. 1996. Sex differences in susceptibility to viral infection of the central nervous system. J. Neuroimmunol. 67:31-39.
2. Bender, B. S., C. A. Rowe, S. F. Taylor, L. S. Wyatt, B. Moss, and P. A. Small, Jr. 1996. Oral immunization with a replication-deficient recombinant virus protects mice against influenza. J. Virol. 70:6418-6424.
3. Brody, J. A., G. F. Fischer, and P. H. Peralta. 1967. Vesicular stomatitis virus in Panama. Human serologic patterns in a cattle raising area. Am. J. Epidemiol. 86:158-161.
4. Castrucci, M. R., P. Bilsel, and Y. Kawaoka. 1992. Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase. J. Virol. 66:4647-4653.
5. Couch, R. B. 1993. Advances in influenza virus vaccine research. Ann. N. Y. Acad. Sci. 685:803-812.
6. Davis, N. L., K. W. Brown, and R. E. Johnston. 1996. A viral vaccine vector that expresses foreign genes in lymph nodes. J. Virol. 70:3781-3787.
7. Dietzschold, B., C. E. Rupprecht, Z. F. Fu, and H. Koprowski. 1996. Rhabdoviruses, p. 1137-1159. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven, Philadelphia, Pa.
8. Fellowes, O. N., G. T. Dimopoullos, and J. J. Callis. 1955. Isolation of vesicular stomatitis virus from an infected laboratory worker. Am. J. Vet. Res. 16:623-626.
9. d system. J. Virol. 65:4950-4958.
10. Hanson, R. P., and C. A. Brandly. 1957. Epizootiology of vesicular stomatitis. Am. J. Public Health 47:205-209.
11. Hanson, R. P., A. F. Rasmussen, Jr., C. A. Brandly, and J. W. Brown. 1950. Human infection with the virus of vesicular stomatitis. J. Clin. Lab. Med. 36:754-758.
12. + cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. J. Virol. 71:5060-5068.
13. Johnson, K. M., J. E. Vogel, and P. H. Peralta. 1966. Clinical and serological response to laboratory-acquired human infection by Indiana type vesicular stomatitis virus (VSV). Am. J. Trop. Med. Hyg. 15:244-246.
14. Kelley, J. M, S. U. Emerson, and R. R. Wagner. 1972. The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody. J. Virol. 10:1231-1235.
15. Kretzschmar, E., L. Buonocore, M. J. Schnell, and J. K. Rose. 1997. High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. J. Virol. 71:5982-5989.
16. Kuno-Sakai, H., M. Kimura, K. Ohta, R. Shimojima, Y. Oh, and H. Fukumi. 1994. Developments in mucosal influenza virus vaccines. Vaccine 12:1303-1310.
17. Lamb, R. A., and R. M. Krug. 1996. Orthomyxoviridae: the viruses and their replication, p. 1353-1395. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven, Philadelphia, Pa.
18. Lawson, N. D., E. A. Stillman, M. A. Whitt, and J. K. Rose. 1995. Recombinant vesicular stomatitis viruses from DNA. Proc. Natl. Acad. Sci. USA 92:4477-4481.
19. Moldoveanu, Z., M. L. Clements, S. J. Prince, B. R. Murphy, and J. Mestecky. 1995. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine 13:1006-1012.
20. Moldoveanu, Z., M. Novak, W. Q. Huang, R. M. Gilley, J. K. Staas, D. Schafer, R. W. Compans, and J. Mestecky. 1993. Oral immunization with influenza virus in biodegradable microspheres. J. Infect. Dis. 167:84-90.
21. Schnell, M. J., L. Buonocore, E. Boritz, H. P. Ghosh, R. Chernish, and J. K. Rose. 1998. Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus, EMBO J. 17: 1289-1296.
22. Schnell, M. J., L. Buonocore, E. Kretzschmar, E. Johnson, and J. K. Rose. 1996. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc. Natl. Acad. Sci. USA 93:11359-11365.
23. Schnell, M. J., J. E. Johnson, L. Buonocore, and J. K. Rose. 1997. Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell 90:849-857.
24. 23a. Tobery, T., E. Johnson, J. K. Rose, and R. Siciliano. Unpublished results.
25. Wagner, R. R., and J. K. Rose. 1996. Rhabdoviridae: the viruses and their replication, p. 1121-1135. In B. N. Fields, D. M. Knipe, P. M. Howley (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven, Philadelphia, Pa.
26. Zinkernagel, R. M., B. Adler, and J. J. Holland. 1978. Cell-mediated immunity to vesicular stomatitis virus infections in mice. Exp. Cell Biol. 46:53-70.